For the majority of the anaesthetics given in the 140 years since the advent of modern anaesthesia, the anaesthetist has relied on his natural senses to monitor the patient, aided, more recently, by a sphygmomanometer and a stethoscope. However, in the last twenty or thirty years, there has been a progressive increase in the availability of monitoring devices: this has become a veritable flood in the last decade. There has also been a trend towards larger operations being performed on sicker patients, and towards an increase in litigation.
Anaesthetists have followed up untoward incidents and have proposed means whereby such incidents might be avoided in the future. Paradoxically, because of a misunderstanding regarding the real role of the morbidity and mortality studies in which our speciaity has played a pioneering role, this has led to a widespread belief that the anaesthetist is usually to blame if a patient dies during or soon after an operation. Despite the fact that anaesthetists are generally careful, conscientious and informed, and have a powerful disincentive to be involved in any anaesthetic death, this has led to the anaesthetist being a prime target for what, at least in the USA., seems to be a litigation growth industry. Whether or not the same trend is occurring in this region,I.2 some anaesthetists here are beginning to feel threatened and demoralised, and some are even contemplating employing the defensive medicine practices that seem necessary in parts of North America. Regrettably, this implies that the doctor's prime responsibility is to himself or herself, and only then, within this constraint, to the patient.
There is no doubt that the use of monitoring devices may yield additional information about the state of the patient, and that some of this information may be useful. However, there is also no doubt that many devices, if used inappropriately, may confuse and mislead the anaesthetist, and may delay and render much more 4 This is not consistent with accepted clinical practice in Australia, and can be carried to ridiculous extremes. Ifsuch an opinion is accepted. it may lead to the widespread use of expensive complex devices with which anaesthetists are unfamiliar in circumstances in which their use may be unnecessary or even inappropriate. There are now a host of monitoring devices available, many of which are promoted by aggressive and occasionally misleading marketing strategies. All anaesthetists support the concept that patients who suffer as a result of negligence should be compensated. However, most do not agree that they should take elaborate, expensive and potentially counter-productive measures in order to 'cover' themselves against inappropriate precedents which have been set on another continent under a different legal system.
On the other hand, anaesthetists take pride in understanding equipment, and are keen to meet the challenge of the technological revolution and ensure that their patients receive the undoubted advantages of some of the recent advances in monitoring. In recent reports from Europe, North America and Australasia, inadequate monitoring appears to have been a major or a contributing factor in about one-fifth of all anaesthesia-related deaths.5-11 In a detailed study from New South Wales, inadequate observation or monitoring was identified as the main cause of death in 8% of cases, and as a likely contributing factor in many others (personal communication, R. Holland, Chairman, Anaesthetic Mortality Committee, N.S.W., 1987) ( Table 1) . In recognising the role of inadequate monitoring in anaesthesia-related morbidity and mortality, minimum standards for patient monitoring at the nine hospitals affiliated with Harvard Medical School were published recently. 12 With some minor changes, these were then endorsed by the American Society of Anesthesiologists. 13 While most anaesthetists in the Australasian region are in full agreement with the basic American requirements (such as the presence of an accredited anaesthetist or supervised trainee, and continuous monitoring of ventilation and the circulation), there is not universal acceptance of every aspect of the requirements. For example, it would seem to be inappropriate in the Australasian-Pacific region to devote funds to the purchase of ECG machines (and electrodes at $2-$3 per patient) for use on every healthy child and young adult when pulse meters and oxygen analysers are not yet universally available, and when the expenditure on disposable electrodes alone would represent at least half the cost per anaesthetic of a pulse oximeter. It would seem to be better to think very carefully about how to spend the limited funds available, and to recognise that throwing technology at the problem is not necessarily the total solution. Yet, as the final advocates for our patients, it is up to us to ensure that they are not denied the benefits of any proven technological advances.
There is general agreement that 70-80% of serious morbidity and mortality is caused by operator error or by inadequate experience, training or knowledge. Inadequate preoperative assessment or resuscitation, use of the wrong technique or drug, overdose and inadequate reversal account for most of these problems. 5-11 The Australasian region seems to have got its priorities right in establishing excellent mechanisms for the training and accreditation of anaesthetists. The training program in Australia takes five years. In the U.S.A., there are as many nurse anaesthetists as consultant anaesthetists (some 20,000 of each), and full specialist accreditation requires only three years training. This emphasis on training in Australasia would seem to be vindicated by the fact that anaesthesia-related mortality seems to have fallen here over the last twenty-five years from about one in 5-10,000 cases (which it currently seems to be in the U.S.A.)14 to about one in 26,000 cases. I I Nevertheless, the time has come to address the question of the role of monitoring in enhancing patient safety and to map a pathway for the Australasian anaesthetist through what has become a minefield of potentially conflicting options.
It was therefore decided to address the problem in a forum attended by as wide a spectrum as possible of experienced anaesthetists with expertise in the area, and to offer every opportunity for open discussion and debate. This meeting was held over five days in Adelaide in May 1987. By establishing a set of guidelines which could be regarded as a generally acceptable standard of practice, it was hoped that the 'unedifying spectacle of disagreement among opposing specialists' would become a rare event. 2 It was decided to recommend, after the most careful possible consideration, minimum monitoring standards for this region. At the same time, it was recognised that consideration should also be given to many other important factors relating to the choice and use of monitoring devices. The role of the new Federal Government Therapeutic Devices Evaluation Committee was outlined. Aspects of evaluation, selection; funding, . purchase, hospital acceptance, servicing, maintenance, calibration and documentation of devices were discussed. Major deficiencies were identified in the exchange of information between state governments, hospitals, engineers and doctors about equipment hazards and defects, and some improvements in this area were proposed. Detailed consideration was given to many aspects of monitoring the supply of compressed gases and of electricity, and also to requirements for checking and monitoring the anaesthetic machine, breathing circuits, ventilators, and the monitors themselves. Pre-anaesthetic assessment, post-anaesthetic safety, ergonomics, anaesthetic records, and monitoring trends and requirements in both public and private hospitals were considered.
The need for education about monitoring and equipment was agreed upon, and some mechanisms for the establishment and implementation of education programs were proposed. The advantages of computerisation of anaesthetic records with common standards and conventions became evident, as this would allow pooling of data and incident reports from many institutions. This would enhance education via institutional and regional quality assurance meetings, and would provide a much-needed database for medical decision making and cost benefit analysis. In addition to ensuring the best value for each 'medical' dollar, this would allow the incidence of rare conditions and complications to be established and would facilitate the development of strategies and protocols for the prevention and management of problems. Finally, both institutional and state-wide morbidity and mortality reporting were discussed, and moves to standardise reporting procedures and classifications were foreshadowed.
The proper management of the interface between biomedical technology and the patient presents a great challenge to the modern anaesthetist. To gain the greatest advantage with finite resources we need to identify what problems are occurring, and then decide on the most efficient and cost-effective way to prevent them or to minimise their adverse effects. To do this will require co-operation among anaesthetists and between industry and the medical profession. Mechanisms will have to be established to gather, analyse and disseminate information efficiently. Procedures will have to be established to continuously update our approaches and to transmit properly processed information to those who provide the funds, those who design and sell the equipment, and those who use it.
In this issue we present as much as possible of the outcome of the May 1987 Monitoring and Patient Safety meeting, and in the final paper we propose mechanisms to enable us to realise some of the goals which were identified.
